IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BB Biotech AG

Q3 2013 Holdings

Filed 2013-11-12 | 24 holdings | $32.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alnylam Pharmaceuticals, Inc.(ALNY)COM02043Q107$30.2M471,28894.3%
Celgene Corp.(CELG)COM151020104$308.2K1,999,2711.0%
Isis Pharmaceuticals, Inc.COM464330109$270.4K7,202,5850.8%
Gilead Sciences, Inc(GILD)COM375558103$228.1K3,627,7140.7%
Incyte Corp.(INCY)COM45337C102$181.7K4,763,2700.6%
Vertex Pharmaceuticals Inc.(VRTX)COM92532F100$106.5K1,404,4450.3%
Alexion Pharmaceuticals, Inc.(ALXN)COM015351109$88.0K757,4280.3%
Medivation, Inc.COM58501N101$86.9K1,449,7060.3%
Ariad Pharmaceuticals, Inc.COM04033A100$67.9K3,689,0710.2%
Halozyme Therapeutics, Inc.(HALO)COM40637H109$60.9K5,516,3220.2%
ImmunoGen, Inc.(IMGNEUR)COM45253H101$55.8K3,275,8160.2%
Pharmacyclics, Inc.COM716933106$55.2K399,0300.2%
Synageva BioPharma Corp.COM87159A103$45.3K714,6020.1%
Onyx Pharmaceuticals, Inc.COM683399109$42.4K339,8700.1%
Theravance, Inc.COM88338T104$36.3K888,2440.1%
Regeneron Pharmaceuticals, Inc.(REGN)COM75886F107$31.9K102,0000.1%
Endocyte, Inc.COM29269A102$30.3K2,269,3450.1%
Clovis Oncology Inc.(CLVSEUR)COM189464100$23.2K381,8860.1%
Infinity Pharmaceuticals Inc.(INFIQ)COM45665G303$22.7K1,300,7370.1%
Neurocrine Biosciences, Inc.(NBIX)COM64125C109$22.1K1,950,1480.1%
Optimer Pharmaceuticals, Inc.COM68401H104$17.9K1,422,2000.1%
Tesaro, Inc.COM881569107$14.5K373,3000.0%
Idenix Pharmaceuticals, Inc.COM45166R204$6.5K1,250,0000.0%
Achillion Pharmaceuticals, Inc.(ACHNEUR)COM00448Q201$5.4K1,779,3400.0%